Fundraising Fox
/Companies
Sign in

CardioSignal

Turku, FI · Founded 2016 · 33 employees on LinkedIn · 5 known investors

Find your way into CardioSignal

Sign up to see every warm intro you have to CardioSignal

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CardioSignal team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

CardioSignal was founded in 2016 by Tuomas Valtonen.

TV
Tuomas ValtonenCOO, Co-founder
JBJuuso Blomster
Juuso BlomsterFounder, CEO
IKIlkka Korhonen
Ilkka KorhonenChief Technology OfficerIlkka Korhonen is an engineer and researcher with three decades of experience developing biosignal algorithms and sensor technologies for consumer wearables and regulated medical devices. He held roles including CTO at Firstbeat Technologies, co-founder and CTO of PulseOn, and has worked at Nokia, Meta, and GE Healthcare; he also held an academic position in ICT for health.
KS
Kristiina SantalahtiResearch & Quality DirectorKristiina Santalahti has spent five years in medical device startups, developing expertise in regulatory strategy and compliance for EU and US markets with a focus on software as a medical device and clinical evidence for regulatory approval. Her background includes a decade of academic research in cardiovascular epidemiology, biomarkers, and immunology.

Investors · 5

Innovestor Ventureslisted by Innovestor VenturesHelsinki · $270K – $3.2M

How we know: Innovestor Ventures's portfolio page · Not right? Tell us

Sandwaterlisted by SandwaterOslo · $2.2M – $11M

How we know: Sandwater's portfolio page · funding news · Not right? Tell us

Start Capitallisted by Start Capital
Maki.vcreportedHelsinki · $324K – $3.2M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$10M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

CardioSignal Raises $10 Million in Series A — CardioSignalcardiosignal.com · Jan 2024CardioSignal - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does CardioSignal do?
CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.
Who founded CardioSignal?
CardioSignal was founded by Tuomas Valtonen in 2016.
Who are CardioSignal's investors?
CardioSignal's investors include DigiTx Partners LLC, Innovestor Ventures, Sandwater, Start Capital, Maki.vc.
How much funding has CardioSignal raised?
CardioSignal has disclosed $10M raised across 1 round.
Where is CardioSignal headquartered?
CardioSignal is headquartered in Turku, FI.